The use of suicide gene systems in vascular cells in vitro

Cell Research

Volumn 8, Issue 1, 1998, Pages 73-78

  Xu, Ling Fei ^a   Xu, De Hua ^a   Ge, Kai ^a   Zheng, Zhong Cheng ^a   Sun, Lan Yin ^a   Liu, Xin Yuan ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Bystander effect; EC CD 5 FC system; Endothelial cell; HSV tk GCV system; Suicide gene

Indexed keywords

CYTOSINE DEAMINASE; DEAMINASE; FLUCYTOSINE; GANCICLOVIR; PRODRUG; THYMIDINE KINASE;

ANGIOGENESIS; ANIMAL; ARTICLE; CELL DIVISION; CELL LINE; CYTOLOGY; DRUG EFFECT; GENE VECTOR; GENETICS; MOUSE; RETROVIRUS; VASCULAR ENDOTHELIUM;

ANIMALS; CELL DIVISION; CELL LINE; CYTOSINE DEAMINASE; ENDOTHELIUM, VASCULAR; FLUCYTOSINE; GANCICLOVIR; GENETIC VECTORS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEOSIDE DEAMINASES; PRODRUGS; RETROVIRIDAE; THYMIDINE KINASE;

EID: 0032016473     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/cr.1998.8     Document Type: Article

References (13)

1. Filder IJ, Ellis LM. The implication of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79:185-8.
2. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285:1182-6.
3. Fan TP, Jaggar R, Bicknell R. Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol. Sci 1995; 16(2):57-66.
4. QG Dong, S Bernasconi, S Lostaglio, RW Calmanocici, IM Padura, F Breviario, et al. A general strategy for isolation of endothelial cells from murine tissues: characteri-zation of two endothelial cell lines obtained from murine lung and subcutaneous sponge implants. Arterioscleriosis, Thrombosis, and Vascular Biology, in press.
5. Bi WL, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 1993; 4(6):725-31.
6. Robert RE, Thierry PC, Bruce RP, Margaret AB, Candace SJ, Ruth AM, et al. Gene therapyand endothelial cell targeting for cancer. Ann NY. Acad Sci 1994; 176:257-64.
7. John DP. Cancer gene therapy: a bystander effect using the gap junctional pathway. MolCarcinogen 1994; 11:127-30.
8. Pitts JD, Kam E, Morgan D. The role of junctional communication in cellular growth controland tumorigenesis. Modern Cell Biol 1992; 7:397-409.
9. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transferwith retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992;256:1550-2.
10. Ram Z, Culver K, Walbridge S, Blaese R, Oldfield E. In situ retroviral-mediated gene transferfor the treatment of brain tumors in rats. Cancer Res. 1993; 53:83-8.
11. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3:65-71.
12. Hobson B, Denekamp J. Endothelial proliferation in tumors and normal tissues: continuouslabelling studies. Br J Cancer 1984; 49(4):405-13.
13. Kaoru M, Daniel EJ, Lewis TW. A novel promoter for vascular endothelial growth factor receptor(flt-1) that confers endothelial-specific gene expression. J Bio Chem 1995; 270(46):27948-53.